SAMe Vitamin E C Combination Therapy for Liver Injury
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antioxidant therapies are inadequate for treating acute liver injury and do not effectively address secondary events such as insulin resistance associated with liver injury, as they fail to target free radicals in both lipid and aqueous phases and have limited efficacy due to imbalanced redox states.
Innovation Solution
A combination therapy using S-adenosylmethionine (SAMe), vitamin E, and vitamin C, which synergistically scavenge free radicals in both aqueous and lipid phases, restoring glutathione stores and improving cellular ability to counteract oxidative stress, thereby treating both acute and chronic liver injuries and associated insulin resistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a single antioxidant is used for treatment, then the treatment is simple, but the efficacy in acute liver injury is insufficient
Solution Approach 1:
The patent combines multiple antioxidants (vitamin C, vitamin E, and other free radical scavengers) into a single therapeutic regimen. This merging of multiple antioxidant agents works synergistically to scavenge free radicals in both aqueous and lipid phases, thereby improving treatment efficacy for acute liver injury while maintaining practical simplicity in administration.
2Adaptability or versatility
If currently available antioxidant therapies are used, then the treatment approach is established, but they fail to address both lipid and aqueous phase free radicals
Solution Approach 1:
The patent employs a multi-functional antioxidant combination where vitamin C primarily scavenges free radicals in the aqueous phase, vitamin E targets free radicals in the lipid phase, and additional antioxidants provide complementary coverage. This universal approach ensures comprehensive protection against oxidative damage across different cellular compartments, thereby enhancing both treatment coverage and effectiveness.
3Object-affected harmful factors
If antioxidant treatment is applied, then oxidative stress is targeted, but secondary events such as insulin resistance are not addressed
Solution Approach 1:
The patent merges antioxidant therapy with metabolic support by combining free radical scavengers with S-adenosylmethionine (SAMe), which has both antioxidant properties and metabolic functions. This combination not only addresses oxidative stress but also improves insulin sensitivity and prevents secondary events like insulin resistance, thereby expanding the therapeutic coverage beyond just oxidative damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of SAMe, vitamin E, and vitamin C effectively reduces the severity of liver injury and insulin resistance by targeting oxidative stress in both cellular compartments, improving liver function and insulin sensitivity, as demonstrated in rat models of acute liver damage.
Implementation Method 1
synergistically scavenge free radicals in both aqueous and lipid phases, restoring glutathione stores and improving cellular ability to counteract oxidative stress
Data Source
AI summary
The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.